Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus

被引：0
|
作者：
Juan Huang
Jun-Xu Gu
Kun Wang
Ai-Min Zhang
Ting-Ting Hong
Shan-Shan Li
Xiao-Qin Yao
Ming Yang
Yue Yin
Na Zhang
Ming Su
Jia-Jia Hu
Xue-Zhi Zhang
Mei Jia
机构：
[1] Peking University International Hospital,Department of traditional Chinese medicine
[2] Peking University People’s Hospital,Department of Clinical Laboratory
[3] Central South University,Department of Clinical Laboratory, Xiangya Hospital
[4] Peking University International Hospital,Department of Clinical Laboratory
来源：
Diabetology & Metabolic Syndrome | / 15卷
关键词：
PCSK9; T2DM; Coronary heart disease; Cardiovascular events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] ASSOCIATION BETWEEN PLASMA LIPIDS, DISEASE ACTIVITY AND PCSK9 LEVELS IN RA PATIENTS
    Heslinga, M.
    Lambert, G.
    Thedrez, A.
    Kastelein, J.
    Nurmohamed, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 259 - 259
  • [42] Serum apolipoprotein J in health, coronary heart disease and Type 2 diabetes mellitus
    Kujiraoka, Takeshi
    Hattori, Hiroaki
    Miwa, Yoshikazu
    Ishihara, Mitsuaki
    Ueno, Takahiro
    Ishii, Jun
    Tsuji, Masahiro
    Iwasaki, Tadao
    Sasaguri, Yoshiyuki
    Fujioka, Takayuki
    Saito, Satoshi
    Tsushima, Motoo
    Maruyama, Taro
    Miller, Irina P.
    Miller, Norman E.
    Egashira, Tohru
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2006, 13 (06) : 314 - 322
  • [43] PCSK9 inhibitors in hypercholesterolemia. New hope for patients with diabetes mellitus?
    Parhofer, K. G.
    HERZ, 2016, 41 (03) : 217 - 223
  • [44] Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus
    Wilson, SH
    Kennedy, FP
    Garratt, KN
    DRUGS & AGING, 2001, 18 (05) : 325 - 333
  • [45] Predictive nomogram for coronary heart disease in patients with type 2 diabetes mellitus
    Xiao, Shucai
    Dong, Youzheng
    Huang, Bin
    Jiang, Xinghua
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [46] Endothelial dysfunction in patients with coronary heart disease and Type 2 diabetes mellitus
    Petina, M. M.
    Gorokhovskaya, G. N.
    Martynov, A., I
    RUSSIAN JOURNAL OF CARDIOLOGY, 2011, (02): : 32 - 36
  • [47] Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus
    Stephanie H. Wilson
    Frank P. Kennedy
    Kirk N. Garratt
    Drugs & Aging, 2001, 18 : 325 - 333
  • [48] STRONG ASSOCIATION BETWEEN SERUM PCSK9 AND CARDIOVASCULAR DISEASE IN PATIENTS WITH MODERATE CHRONIC KIDNEY DISEASES THE GCKD STUDY
    Kheirkhah, A.
    Lamina, C.
    Kollerits, B.
    Schachtl-Riess, J. F.
    Schultheiss, U. T.
    Forer, L.
    Sekula, P.
    Ottgen, F. Kotsis A. K.
    Eckardt, K. -U.
    Kronenberg, F.
    ATHEROSCLEROSIS, 2021, 331 : E48 - E48
  • [49] Circulating PCSK9 is associated with pentraxin 3 concentration in patients with type 2 diabetes
    Walus, M.
    Kapusta, M.
    Trojak, A.
    Miarka, P.
    Idzior-Walus, B.
    Malecki, M. T.
    DIABETOLOGIA, 2017, 60 : S569 - S570
  • [50] Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control
    Bojanin, Dragana
    Vekic, Jelena
    Milenkovic, Tatjana
    Vukovic, Rade
    Zeljkovic, Aleksandra
    Stefanovic, Aleksandra
    Janac, Jelena
    Ivanisevic, Jasmina
    Mitrovic, Katarina
    Miljkovic, Milica
    Spasojevic-Kalimanovska, Vesna
    ATHEROSCLEROSIS, 2019, 280 : 14 - 20
12345